The company's plan to expand its vaccine production capacity from 2 million to 3 million doses is now in line with the HPV vaccine against cervical...
From newer therapies for Alzheimer’s disease to developing off-the-shelf gene therapies for cancer, 2024 holds out hope for exciting developments in medicine that can transform our...
More than 600,000 new cases of cervical cancer and more than 3,40,000 deaths from the disease were reported worldwide in 2020, according to an observational study...
CERVAVAC, the first vaccine developed in India to prevent cervical cancer, was developed by SII CERVAVAC, the first vaccine developed in India to prevent cervical cancer,...
SII CEO Adar Poonawalla told Business Standard that it is working with US-based technology company Greenlight Biosciences to manufacture mRNA vaccines for a small number of...
India has reported four cases of monkeypox so far, and the Indian Serum Institute (SII) has reported that it is negotiating with the Danish company Bavarian...
Recent Comments